Skip to content

Virtual Reality for Patient Preparation Before Cardiac Catheterization in Oman

Evaluating the Efficacy of Virtual Reality in Patient Preparation for Cardiac Catheterization Procedures in Oman: A Randomized Controlled Trial

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07320248
Enrollment
120
Registered
2026-01-06
Start date
2026-03-05
Completion date
2027-06-30
Last updated
2026-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Catheterization, Coronary Artery Disease, Ischaemic Heart Desease

Brief summary

Background: Cardiovascular disease is considered one of the most prevalent diseases in recent times, and cardiac catheterization is widely used to diagnose and treat cardiovascular disease. However, patients often experience significant anxiety before the procedure due to fear of the unknown, potential complications, and concern about discomfort.Aim: To evaluate the efficacy of virtual reality technology to reduce anxiety and improve patient satisfaction, attitude, and usefulness in individuals undergoing first-time cardiac catheterization procedures in Oman.Method: A mixed-method randomized control trial will be used with approximately 120 patients from different tertiary hospitals in Oman. The experimental group will experience a virtual reality simulation of the catheterization process before providing informed consent, while the control group will receive the standard pre-procedure education. The Arabic version of the DASS-21 scale will be used to assess anxiety level pre- and post-intervention, while patient satisfaction will be measured through qualitative interviews with a subset of 10 participants.Result: ANOVA will be conducted to examine differences in anxiety and satisfaction scores between groups, and Pearson's correlation (r) will assess relationships between anxiety levels and satisfaction scores, while paired t-tests will be applied to compare anxiety levels before and after the intervention within groups. Additionally, multiple regression analysis will be employed to identify predictors of patient satisfaction and anxiety reduction, with a significance level set at p ≤ 0.05 for all statistical tests.Conclusion: The expected outcome of this study is that virtual reality-based education will significantly reduce pre-procedure anxiety and enhance patient satisfaction compared to standard education. Findings from this research may contribute to improving patient-centered care and developing innovative strategies to optimize emotional preparedness before cardiac catheterization procedures.

Interventions

Participants in this group will receive a virtual reality-based educational session prior to their first cardiac catheterization. The VR module provides an immersive 3D orientation to the catheterization process, including admission, preparation, transfer to the Cath Lab, procedural steps, and post-procedure recovery. The VR session lasts approximately 10-15 minutes and is delivered once in a quiet hospital setting before the scheduled procedure. This innovative approach aims to enhance patient understanding and reduce anxiety associated with the catheterization experience. By familiarizing participants with the entire process beforehand, the program seeks to improve overall satisfaction and outcomes.

Sponsors

Sultan Qaboos University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Outcomes Assessor)

Masking description

Participants and care providers will be aware of group allocation due to the nature of the intervention. However, the outcomes assessor analyzing the questionnaire data will be blinded to group assignment.

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* • Adult patients (aged 18 years and above) * Scheduled for first-time elective cardiac catheterization * Able to understand Arabic or English * Capable of providing informed consent

Exclusion criteria

* • Individuals with cognitive impairment or psychiatric conditions that may interfere with their ability to engage in the VR intervention * Patients requiring emergency or urgent catheterization

Design outcomes

Primary

MeasureTime frameDescription
Change in pre-procedural anxiety (measured by DASS-21 Anxiety Subscale)Baseline (before intervention) to immediately prior to cardiac catheterization (within 24 hours).Anxiety will be assessed using the Depression, Anxiety and Stress Scale - 21 (DASS-21). The Anxiety subscale includes 7 items, each scored 0-3. Subscale scores are multiplied by 2, giving a final range of 0-42. Higher scores indicate greater anxiety.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026